-$0.04 EPS Expected for Evolent Health Inc (EVH) This Quarter
Wall Street analysts expect that Evolent Health Inc (NYSE:EVH) will announce ($0.04) earnings per share for the current fiscal quarter, Zacks reports. Nine analysts have issued estimates for Evolent Health’s earnings. The highest EPS estimate is ($0.02) and the lowest is ($0.07). Evolent Health reported earnings per share of ($0.18) during the same quarter last year, which would indicate a positive year over year growth rate of 77.8%. The company is scheduled to issue its next quarterly earnings report after the market closes on Tuesday, February 27th.
On average, analysts expect that Evolent Health will report full-year earnings of ($0.36) per share for the current fiscal year, with EPS estimates ranging from ($0.40) to ($0.32). For the next fiscal year, analysts forecast that the firm will report earnings of ($0.05) per share, with EPS estimates ranging from ($0.07) to ($0.03). Zacks Investment Research’s EPS averages are an average based on a survey of research analysts that cover Evolent Health.
Several equities research analysts have commented on the company. Jefferies Group set a $22.00 price objective on Evolent Health and gave the stock a “buy” rating in a research report on Tuesday. Robert W. Baird restated a “buy” rating and issued a $25.00 price objective on shares of Evolent Health in a research report on Wednesday, November 1st. Citigroup assumed coverage on Evolent Health in a research report on Thursday, January 4th. They issued a “buy” rating on the stock. Leerink Swann set a $25.00 price objective on Evolent Health and gave the stock a “buy” rating in a research report on Saturday, November 18th. Finally, Cantor Fitzgerald restated a “buy” rating and issued a $30.00 price objective on shares of Evolent Health in a research report on Thursday, November 2nd. Two analysts have rated the stock with a sell rating, one has assigned a hold rating and thirteen have given a buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and a consensus price target of $27.40.
Shares of Evolent Health (EVH) remained flat at $$14.25 during midday trading on Friday. 498,565 shares of the company were exchanged, compared to its average volume of 725,982. The company has a quick ratio of 3.34, a current ratio of 3.34 and a debt-to-equity ratio of 0.11. Evolent Health has a 1 year low of $10.30 and a 1 year high of $27.50. The stock has a market cap of $1,102.04, a PE ratio of -12.61 and a beta of 1.24.
Evolent Health Company Profile
Evolent Health, Inc is engaged in healthcare delivery and payment. The Company supports health systems and physician organizations in their migration toward value-based care and population health management. The Company provides an end-to-end, technology-enabled services platform for providers. The Company’s platform, powered by its technology, processes and integrated services, enables providers to migrate their economic orientation from fee-for-service (FFS) reimbursement to payment models that reward value-based payment models.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Evolent Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evolent Health and related companies with MarketBeat.com's FREE daily email newsletter.